New Enterprise Associates 16, L.p. - Net Worth and Insider Trading
New Enterprise Associates 16, L.p. Net Worth
The estimated net worth of New Enterprise Associates 16, L.p. is at least $202 Million dollars as of 2024-05-03. New Enterprise Associates 16, L.p. is the 10% Owner of Mirum Pharmaceuticals Inc and owns about 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $108 Million. New Enterprise Associates 16, L.p. is the 10% Owner of Akouos Inc and owns about 4,294,207 shares of Akouos Inc (AKUS) stock worth over $57 Million. New Enterprise Associates 16, L.p. is also the 10% Owner of Trevi Therapeutics Inc and owns about 10,421,428 shares of Trevi Therapeutics Inc (TRVI) stock worth over $32 Million. Besides these, New Enterprise Associates 16, L.p. also holds Marker Therapeutics Inc (MRKR) , Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) . Details can be seen in New Enterprise Associates 16, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that New Enterprise Associates 16, L.p. has not made any transactions after 2022-05-25 and currently still holds the listed stock(s).
Transaction Summary of New Enterprise Associates 16, L.p.
New Enterprise Associates 16, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, New Enterprise Associates 16, L.p. owns 10 companies in total, including Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) , and Akouos Inc (AKUS) among others .
Insider Ownership Summary of New Enterprise Associates 16, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MTCR | Metacrine Inc | 2021-12-22 | 10 percent owner |
| GNCAQ | Genocea Biosciences Inc | 2022-05-25 | 10 percent owner |
| AKUS | Akouos Inc | 2020-06-30 | 10 percent owner |
 | | 2022-04-11 | 10 percent owner |
| | 2020-01-29 | 10 percent owner |
| | 2017-07-24 | 10 percent owner |
| | 2019-07-22 | 10 percent owner |
| | 2021-03-16 | 10 percent owner |
| | 2017-11-20 | 10 percent owner |
| | 2018-01-19 | 10 percent owner |
New Enterprise Associates 16, L.p. Latest Holdings Summary
New Enterprise Associates 16, L.p. currently owns a total of 6 stocks. Among these stocks, New Enterprise Associates 16, L.p. owns 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) as of July 22, 2019, with a value of $108 Million and a weighting of 53.71%. New Enterprise Associates 16, L.p. owns 4,294,207 shares of Akouos Inc (AKUS) as of June 30, 2020, with a value of $57 Million and a weighting of 28.27%. New Enterprise Associates 16, L.p. also owns 10,421,428 shares of Trevi Therapeutics Inc (TRVI) as of April 11, 2022, with a value of $32 Million and a weighting of 15.74%. The other 3 stocks Marker Therapeutics Inc (MRKR) , Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) have a combined weighting of 2.28% among all his current holdings.
Latest Holdings of New Enterprise Associates 16, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 4,186,243 | 25.91 | 108,444,625 |
| AKUS | Akouos Inc | 2020-06-30 | 4,294,207 | 13.29 | 57,070,011 |
| TRVI | Trevi Therapeutics Inc | 2022-04-11 | 10,421,428 | 3.05 | 31,785,355 |
| MRKR | Marker Therapeutics Inc | 2021-03-16 | 1,071,429 | 4.29 | 4,601,359 |
| MTCR | Metacrine Inc | 2021-12-22 | 2,563,257 | 0.00 | 3,589 |
| GNCAQ | Genocea Biosciences Inc | 2022-05-25 | 0 | 0.00 | 0 |
Holding Weightings of New Enterprise Associates 16, L.p.
New Enterprise Associates 16, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, New Enterprise Associates 16, L.p. has made a total of 1 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 450,000 shares on July 22, 2019, which cost New Enterprise Associates 16, L.p. around $7 Million.
According to the SEC Form 4 filings, New Enterprise Associates 16, L.p. has made a total of 1 transactions in Akouos Inc (AKUS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Akouos Inc is the acquisition of 588,235 shares on June 30, 2020, which cost New Enterprise Associates 16, L.p. around $10 Million.
According to the SEC Form 4 filings, New Enterprise Associates 16, L.p. has made a total of 3 transactions in Trevi Therapeutics Inc (TRVI) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in Trevi Therapeutics Inc is the acquisition of 2,631,578 shares on April 11, 2022, which cost New Enterprise Associates 16, L.p. around $5 Million.
More details on New Enterprise Associates 16, L.p.'s insider transactions can be found in the Insider Trading History of New Enterprise Associates 16, L.p. table.Insider Trading History of New Enterprise Associates 16, L.p.
- 1
New Enterprise Associates 16, L.p. Trading Performance
GuruFocus tracks the stock performance after each of New Enterprise Associates 16, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by New Enterprise Associates 16, L.p. is -0.54%. GuruFocus also compares New Enterprise Associates 16, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by New Enterprise Associates 16, L.p. within 3 months outperforms 3 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how New Enterprise Associates 16, L.p.'s insider trading performs compared to the benchmark.
Performance of New Enterprise Associates 16, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.28 | | | | | |
| Relative Return to S&P 500(%) | -1.83 | | | | | |
New Enterprise Associates 16, L.p. Ownership Network
New Enterprise Associates 16, L.p. Owned Company Details
What does Metacrine Inc do?
Who are the key executives at Metacrine Inc?
New Enterprise Associates 16, L.p. is the 10 percent owner of Metacrine Inc. Other key executives at Metacrine Inc include Chief Business Officer Michael York , director & President & CEO Preston Klassen , and 10 percent owner Braden Michael Leonard .
Metacrine Inc (MTCR) Insider Trades Summary
Over the past 18 months, New Enterprise Associates 16, L.p. made no insider transaction in Metacrine Inc (MTCR). Other recent insider transactions involving Metacrine Inc (MTCR) include a net purchase of 435,875 shares made by Braden Michael Leonard , a net sale of 380,605 shares made by Preston Klassen , and a net sale of 107,054 shares made by Michael York .
In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 487,659 shares of Metacrine Inc (MTCR) were sold and 435,875 shares were bought by its insiders, resulting in a net sale of 51,784 shares.
Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Metacrine Inc Insider Transactions
New Enterprise Associates 16, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for New Enterprise Associates 16, L.p.. You might contact New Enterprise Associates 16, L.p. via mailing address: 1954 Greenspring Drive, Suite 600, Timonium Md 21093.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
